Search｜Photos & Images & Videos｜KYODO NEWS IMAGES INC

Cannes - Chopard Trophy Event

Doli Grace attending the photocall for the Chopard Trophy at the 78th annual Cannes Film Festival at Carlton Beach on May 16, 2025 in Cannes, France. Photo by IPA/ABACAPRESS.COM

E

Cannes - Chopard Trophy Event

Doli Grace attending the photocall for the Chopard Trophy at the 78th annual Cannes Film Festival at Carlton Beach on May 16, 2025 in Cannes, France. Photo by IPA/ABACAPRESS.COM

E

coust-doli

Illustration of Doliprane boxes from the SANOFI Opella laboratory in Marseille, France on October 11, 2024. Sanofi's Doliprane to become American with CD&R's takeover of Opella. The French pharmaceutical group has confirmed that it is in exclusive negotiations with CD&R. The American fund is seeking to acquire its Opella subsidiary, which produces Doliprane. Photo by Coust Laurent/ABACAPRESS.COM

E

coust-doli

Illustration of Doliprane boxe from the SANOFI Opella laboratory in Marseille, France on October 11, 2024. Sanofi's Doliprane to become American with CD&R's takeover of Opella. The French pharmaceutical group has confirmed that it is in exclusive negotiations with CD&R. The American fund is seeking to acquire its Opella subsidiary, which produces Doliprane. Photo by Coust Laurent/ABACAPRESS.COM

E

coust-doli

Illustration of Doliprane boxes from the SANOFI Opella laboratory in Marseille, France on October 11, 2024. Sanofi's Doliprane to become American with CD&R's takeover of Opella. The French pharmaceutical group has confirmed that it is in exclusive negotiations with CD&R. The American fund is seeking to acquire its Opella subsidiary, which produces Doliprane. Photo by Coust Laurent/ABACAPRESS.COM

E

coust-doli

Illustration of Doliprane boxes from the SANOFI Opella laboratory in Marseille, France on October 11, 2024. Sanofi's Doliprane to become American with CD&R's takeover of Opella. The French pharmaceutical group has confirmed that it is in exclusive negotiations with CD&R. The American fund is seeking to acquire its Opella subsidiary, which produces Doliprane. Photo by Coust Laurent/ABACAPRESS.COM

E

coust-doli

Illustration of Doliprane tablet from the SANOFI Opella laboratory in Marseille, France on October 11, 2024. Sanofi's Doliprane to become American with CD&R's takeover of Opella. The French pharmaceutical group has confirmed that it is in exclusive negotiations with CD&R. The American fund is seeking to acquire its Opella subsidiary, which produces Doliprane. Photo by Coust Laurent/ABACAPRESS.COM

E

coust-doli

Illustration of Lysopaine boxe from the SANOFI Opella laboratory in Marseille, France on October 11, 2024. Sanofi's Doliprane to become American with CD&R's takeover of Opella. The French pharmaceutical group has confirmed that it is in exclusive negotiations with CD&R. The American fund is seeking to acquire its Opella subsidiary, which produces Doliprane. Photo by Coust Laurent/ABACAPRESS.COM

E

coust-doli

Illustration of Doliprane boxe from the SANOFI Opella laboratory in Marseille, France on October 11, 2024. Sanofi's Doliprane to become American with CD&R's takeover of Opella. The French pharmaceutical group has confirmed that it is in exclusive negotiations with CD&R. The American fund is seeking to acquire its Opella subsidiary, which produces Doliprane. Photo by Coust Laurent/ABACAPRESS.COM

E

coust-doli

Illustration of Doliprane boxes from the SANOFI Opella laboratory in Marseille, France on October 11, 2024. Sanofi's Doliprane to become American with CD&R's takeover of Opella. The French pharmaceutical group has confirmed that it is in exclusive negotiations with CD&R. The American fund is seeking to acquire its Opella subsidiary, which produces Doliprane. Photo by Coust Laurent/ABACAPRESS.COM